KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Albemarle (ALB) EBIT (2016 - 2025)

Historic EBIT for Albemarle (ALB) over the last 17 years, with Q4 2025 value amounting to $197.9 million.

  • Albemarle's EBIT rose 4320.94% to $197.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $382.8 million, marking a year-over-year increase of 16001.08%. This contributed to the annual value of -$367.1 million for FY2025, which is 7933.72% up from last year.
  • Per Albemarle's latest filing, its EBIT stood at $197.9 million for Q4 2025, which was up 4320.94% from $117.6 million recorded in Q3 2025.
  • Over the past 5 years, Albemarle's EBIT peaked at $1.1 billion during Q1 2023, and registered a low of -$849.9 million during Q4 2023.
  • Moreover, its 5-year median value for EBIT was $134.9 million (2021), whereas its average is $163.3 million.
  • Per our database at Business Quant, Albemarle's EBIT surged by 276256.15% in 2022 and then crashed by 45187.0% in 2024.
  • Quarter analysis of 5 years shows Albemarle's EBIT stood at -$31.3 million in 2021, then soared by 2762.56% to $833.0 million in 2022, then plummeted by 202.02% to -$849.9 million in 2023, then skyrocketed by 116.26% to $138.2 million in 2024, then surged by 43.21% to $197.9 million in 2025.
  • Its EBIT stands at $197.9 million for Q4 2025, versus $117.6 million for Q3 2025 and $47.5 million for Q2 2025.